患有晚期慢性肝病的病人:什么时候使用每个分数?
Oliver Moore1,2, Wai-See Ma1,2, Scott Read1,2,3
1Blacktown Clinical School, School of Medicine, Western Sydney University, Blacktown, NSW, Australia.
BMC medicine
|July 8, 2025
概括
本综述探讨了慢性肝病的预后评分系统,包括Child-Pugh,MELD和ACLF评分. 了解得分限制对于在不同患者群体中准确预后至关重要.
科学领域:
- 肝病学和胃肠道学
- 临床预测 临床预测
- 医学评分系统 医学评分系统
背景情况:
- 慢性肝病的预后是复杂的,因为不同的临床表现.
- 了解评分系统的局限性和发展背景对于适当的应用至关重要.
- 本综述侧重于补偿/脱补偿肝病,慢性肝衰竭急性肝癌 (ACLF) 和肝细胞癌 (HCC) 的预测得分.
研究的目的:
- 探索慢性肝病中各种预测分数的最佳临床用途.
- 审查未来的研究方向,并确定每个分数的文献差距.
- 为指导在晚期肝病中预后得分的有效应用.
主要方法:
- 对肝病中已建立和新兴的预后评分系统的审查.
- 分析开发,验证和临床效用等分数的儿童-普赫,MELD变体,FIPS,CLIF-C AD/ACLF,和白蛋白-白素.
- 讨论人工智能在个性化预后中的作用.
主要成果:
- 查尔德 - 普格评分对于HCC切除选择是有用的,但对于急性失补偿症的生存来说却不那么有用.
- MELD及其变体 (MELD-Na,MELD 3.0) 用于TIPS死亡率预测和器官分配,MELD 3.0解决了性别差异.
- 根据CLIF-C的AD和ACLF得分,分别预测了急性衰减和ACLF的肝硬化患者的死亡率.
- 专-胆氨基分数提供了非侵入性HCC生存预测.
- 人工智能集成显示了个性化预测的前景.
结论:
- 已经总结了晚期肝病的关键预后得分.
- 提供了最佳得分利用的建议.
- 讨论了得分开发和实施的细微差别,以加强临床指导.
更多相关视频
相关概念视频
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
209
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
209
01:29Chronic Pancreatitis II: Collaborative Care
131
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
131
01:28Esophageal Varices-II: Clinical Features and Management
147
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
147
01:26Diseases of the Liver and Gallbladder
1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K